Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04565496
Title Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients (PEM-PRO)
Acronym PEM-PRO
Recruitment Unknown status
Gender male
Phase Phase II
Variant Requirements No
Sponsors IRCCS San Raffaele
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.